We are live on ! Find out more
SFI

Susquehanna Fundamental Investments Portfolio holdings

AUM $2.67B
1-Year Est. Return 21.74%
This Fund
S&P 500
This Quarter Est. Return
+9.33%
1 Year Est. Return
+21.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.56B
AUM Growth
-$1.16B
Cap. Flow
-$1.34B
Cap. Flow %
-52.42%
Top 10 Hldgs %
19%
Holding
789
New
81
Increased
36
Reduced
304
Closed
239

Top Sells

Rank Stock Value
1
FIX icon
Comfort Systems
FIX
+$63.8M
2
CI icon
Cigna
CI
+$47.4M
3
PYPL icon
PayPal
PYPL
+$36M
4
IBM icon
IBM
IBM
+$32.6M
5
JPM icon
JPMorgan Chase
JPM
+$31.6M

Sector Composition

Rank Sector Weight
1 Industrials 16.14%
2 Technology 16.12%
3 Financials 15.68%
4 Healthcare 8.97%
5 Consumer Discretionary 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVO icon
526
Mission Produce
AVO
$1.13B
$147K 0.01%
12,244
-9,847
-45% -$122K
CCRN
527
DELISTED
Cross Country Healthcare
CCRN
$145K 0.01%
10,188
-8,406
-45% -$111K
XERS icon
528
Xeris Biopharma Holdings
XERS
$1.55B
$139K 0.01%
17,087
PHAT icon
529
Phathom Pharmaceuticals
PHAT
$742M
$135K 0.01%
11,473
AMPL icon
530
Amplitude
AMPL
$1.55B
$132K 0.01%
12,339
-16,850
-58% -$200K
KALV
531
DELISTED
KalVista Pharmaceuticals
KALV
$130K 0.01%
10,686
-18,198
-63% -$251K
FSLY icon
532
Fastly Inc
FSLY
$4.54B
$130K 0.01%
+15,220
New +$113K
SPCE icon
533
Virgin Galactic
SPCE
$500M
$125K ﹤0.01%
32,497
BLND icon
534
Blend Labs
BLND
$331M
$119K ﹤0.01%
+32,608
New +$117K
AIP icon
535
Arteris
AIP
$1.39B
$113K ﹤0.01%
+11,200
New +$107K
NOK icon
536
Nokia
NOK
$57.6B
$102K ﹤0.01%
21,271
-84,100
-80% -$380K
ACB
537
Aurora Cannabis
ACB
$237M
$99.5K ﹤0.01%
+16,700
New +$81.5K
EDIT icon
538
Editas Medicine
EDIT
$436M
$95.9K ﹤0.01%
27,642
ORN icon
539
Orion Group Holdings
ORN
$402M
$85.6K ﹤0.01%
+10,289
New +$81.1K
HTT
540
High Templar Tech Ltd
HTT
$391M
$76.9K ﹤0.01%
+18,009
New +$72.2K
VNDA icon
541
Vanda Pharmaceuticals
VNDA
$314M
$75.5K ﹤0.01%
15,137
-8,578
-36% -$39.7K
RBBN icon
542
Ribbon Communications
RBBN
$372M
$69.9K ﹤0.01%
18,401
+7,301
+66% +$28.7K
VTYX
543
DELISTED
Ventyx Biosciences
VTYX
$64.6K ﹤0.01%
20,777
-26,630
-56% -$70.6K
ACCO icon
544
Acco Brands
ACCO
$399M
$61.5K ﹤0.01%
15,422
-43,332
-74% -$169K
SABR icon
545
Sabre
SABR
$831M
$58.2K ﹤0.01%
31,809
-10,927
-26% -$25.8K
RERE
546
ATRenew
RERE
$988M
$53.1K ﹤0.01%
11,543
-35,195
-75% -$142K
TBLA icon
547
Taboola.com
TBLA
$1.05B
$49.5K ﹤0.01%
14,522
-37,557
-72% -$129K
HTZWW
548
Hertz Global Holdings Warrants
HTZWW
$112M
$48.5K ﹤0.01%
13,092
SB icon
549
Safe Bulkers
SB
$760M
$46K ﹤0.01%
+10,354
New +$43.9K
AGL icon
550
Agilon Health
AGL
$1.45B
$25.6K ﹤0.01%
993

Similar funds

Susquehanna Fundamental Investments's Q3 2025 Portfolio in Review

As of Q3 2025, Susquehanna Fundamental Investments held 789 positions worth $2.56B, down 31% from $3.72B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Susquehanna Fundamental Investments withdrew a net $1.34B in Q3 2025, closing 239 positions and reducing 304 holdings. Its most notable exit was Cigna, an estimated $47.4M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

Against the trend, Susquehanna Fundamental Investments opened a new position in Salesforce worth $44.6M.

  • Susquehanna Fundamental Investments's largest Q3 2025 buy was Salesforce: 188,091 shares worth $44.6M.
  • Susquehanna Fundamental Investments added most to Chubb in Q3 2025, an estimated $17.3M increase.
  • Susquehanna Fundamental Investments's biggest Q3 2025 reduction was Comfort Systems, cutting an estimated $63.8M.
  • Susquehanna Fundamental Investments fully exited Cigna in Q3 2025, selling an estimated $47.4M.
  • Susquehanna Fundamental Investments's ten largest holdings make up 19% of its $2.56B portfolio in Q3 2025.
  • Susquehanna Fundamental Investments opened 81 new positions and closed 239 in Q3 2025.
  • Susquehanna Fundamental Investments's portfolio value fell 31% quarter-over-quarter to $2.56B.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2025, filed 14 Nov 2025.